←Back to Expert Scholars
Translational Medicine / 转化医学MET Exon 14 Skipping Alterations
Shun Lu
MD
🏢Shanghai Chest Hospital🌐China
Professor and Chief, Department of Lung Cancer
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Shun Lu is a leading Chinese thoracic oncologist who has been integral to MET-targeted therapy development in Asia. He led the pivotal savolitinib trial in Chinese patients with MET exon 14 skipping alterations. His contributions span molecular diagnostics implementation and treatment guideline development in China.
Share:
🧪Research Fields 研究领域
MET exon 14 skipping
Savolitinib
NSCLC China
Molecular oncology
Targeted therapy development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Shun Lu 的研究动态
Follow Shun Lu's research updates
留下邮箱，当我们发布与 Shun Lu（Shanghai Chest Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment